National Cancer Registry

Definition	A cancer registry is defined as a location, be it an office or institution, where collection, storage, analysis and interpretation of data on cancer patients take place (Jenson et al, 1991).
Objectives	- To measure cancer incidence - To describe cancer by time, place, persons and disease - To provide a national database for further epidemiological research
Case definition	Target cases are: - Incident cases by year of diagnosis - Malignant tumors confirmed by histopathology and/or hematology findings - Cancers of all sites
Sources of data	Data are collected through two main channels: the capture system (passive reporting) and the recapture system (active reporting). 1) The capture system: The capture system is based on physician’s routine reporting of cancer cases. Physician’s complete and send forms: - Directly from their clinic; or - Indirectly through the MOPH Drug Dispensing Center (DDC), where anti-cancer drugs are distributed to eligible patients 2) The recapture system: The recapture system is based on gathering information directly from histopathological and hematological laboratories. Data are collected in various ways, using hard or soft copies, or using database file or individual laboratory results depending on laboratories resources. This process is active since the NCR personnel actually contact the sites to obtain the necessary data. The recapture system validates and complements the capture approach.
Medical coding	The coding of cancer primary sites and cancer morphology is done using International Classification of Diseases for Oncology, third edition (ICD-O-3). The code includes information on the topography (primary site), the histology, the behavior and the grade of the tumor. The structure is C##.# M####/##, where: - C##.# specifies the primary site - M#### specifies the histology - /## specifies the behavior and the grade of the tumor
Reporting form	NCR reporting form

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N07CA02	CINARIN	G	Cinnarizine - 75mg	75mg	Capsule	490,183 L.L
N07CA02	CINNARIZINE	G	Cinnarizine - 75mg	75mg	Capsule	386,515 L.L
B01AC04	CERUVIN	G	Clopidogrel (Bisulfate) - 75mg	75mg	Tablet	240,548 L.L
B01AC04	CLOPI TAD	G	Clopidogrel (Bisulfate) - 75mg	75mg	Tablet, film coated	911,125 L.L
B01AC04	CLOPIDOGREL ARROW	G	Clopidogrel besylate - 75mg	75mg	Tablet, film coated	658,483 L.L
B01AC04	CLOPIKEY	G	Clopidogrel (Bisulfate) - 75mg	75mg	Tablet	748,520 L.L
B01AC04	CLODOR	G	Clopidogrel (Bisulfate) - 75mg	75mg	Tablet	1,148,025 L.L
B01AC04	CLOTRIX 75	G	Clopidogrel (hydrogenosulfate) - 75mg	75mg	Tablet, film coated	1,109,630 L.L
B01AC04	CLOTRIX 75	G	Clopidogrel (hydrogenosulfate) - 75mg	75mg	Tablet, film coated	1,035,399 L.L
M01AB05	CLOFEN	G	Diclofenac sodium - 75mg/3ml	75mg/3ml	Injectable solution	299,677 L.L
G03DA04	CRINONE	B	Progesterone - 8%	8%	Gel	4,734,357 L.L
N06BX03	CEBROTONIN	G	Piracetam - 800mg	800mg	Tablet, film coated	577,852 L.L
C09CA06	CANDESARTAN BIOGARAN	G	Candesartan cilexetil - 8mg	8mg	Tablet, scored	434,061 L.L
G03GA05	CINNAL-f	BioHuman	Follitropin alfa - 900IU/1.5ml	900IU/1.5ml	Injectable solution	14,826,544 L.L
H05BX01	CINACALCET ARROW	BioTech	Cinacalcet - 90mg	90mg	Tablet, coated, scored	22,062,995 L.L
M01AH05	CONSORT	G	Etoricoxib - 90mg	90mg	Tablet, film coated	338,648 L.L
M01AH05	CLINTON	G	Etoricoxib - 90mg	90mg	Tablet, film coated	454,219 L.L
M01AH05	CLINTON	G	Etoricoxib - 90mg	90mg	Tablet, film coated	1,280,682 L.L
M01AH05	COXIFLAM	G	Etoricoxib - 90mg	90mg	Tablet, film coated	1,293,928 L.L
A07EA06	CORTIMENT MMX	B	Budesonide - 9mg	9mg	Tablet, prolonged release	8,996,996 L.L

National Cancer Registry (NCR)